The global drug delivery market size is forecasted to reach USD 1,801.54 billion by 2026, attributable to the rapid development of the pharmaceutical industry and the advent of drug delivery systems worldwide. The rising trend of digitalization in the pharmaceutical industry has propelled the demand for drug delivery systems for accurate, convenient, and systematic drug concentration for patients. As per a recently published report by Fortune Business insights™ titled, “Drug Delivery Market Size, Share & Industry Analysis, By Route of Administration (Injectable, Inhalation, Topical & Transdermal, Oral and Others), By Type (Conventional and Advanced), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) and Regional Forecast, 2020-2026,” The global drug delivery market size stood at USD 1,021.29 billion in 2018 and is projected to reach USD 1,801.54 billion by 2026, exhibiting a CAGR of 7.4% during the forecast period.

What is the Scope of the Report?

The report on this Market offers an extensive overview of the market, focusing on significant growth drivers, restraints, challenges, and opportunities. It also throws light on the competitive landscape, the list of players operating in the market, and the key strategies adopted by the players to gain a competitive edge in the market. Additionally, the report lists the table of market segmentation based on factors such as route of administration, type, distribution channel, and geographies. Furthermore, the report offers exciting insights and key industry developments of the market that will help players make wise decisions in terms of financial investments during the forecast period. For more information on current Drug Delivery Market trends, or to purchase the report, log on to the company website.

Which Factors Affect the Market Growth?

Rising Popularity of Smart Wearables will Aid in Expansion of Market

There has been a rise in demand for advanced drug delivery devices on account of increasing launch of innovative products, sufficing to consumer satisfaction and efficiency. This is a significant factor in boosting this Market growth. In addition, the advent of smart technology, user-friendly operations, and large volume doses are other factors aiding in the expansion of the market. Furthermore, the increasing popularity of wearables, insulin jets, ocular inserts, and others are likely to help the market gain impetus in the forecast period.

Geographical Segmentation:

Favorable Reimbursement Policies by Governments to Help North America Continue Dominance

From a geographical viewpoint, the global Drug Delivery Market is widespread into the regions of Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa. Among these, North America emerged dominant with a revenue generation of $428.0 billion in 2018. This is attributed to the favorable health reimbursement supported by the regional government, and increasing inclination towards elderly care.

On the other side, the growing population in nations such as India, and China, improving healthcare infrastructure, and the rising awareness about this market will help attract remarkable Market revenue in Asia Pacific during the forecast period.

Competitive Landscape:

Massive Investments for Product Development to Set High Bars for Players

The Drug Delivery Market is fragmented in nature. Manufacturers are focusing on expanding their product portfolio over various geographies by making huge monetary investments for research and development of better therapeutic products suitable for drug delivery devices. Apart from this, players are adopting other strategies such as company collaborations, merger and acquisition, contracts and agreements, joint ventures, and others to compete for the top position in the market and attract high market revenue in the coming years.

List of Major Drug Delivery Market Manufacturers are as Follows:

  • SHL Medical AG.
  • Insulet Corporation
  • Aptar Pharma
  • Consort Medical plc
  • BD
  • Pfizer Inc.
  • Nemera
  • West Pharmaceutical Services Inc.
  • Emergent Biosolutions Inc.
  • Others

Key Industry Developments of Drug Delivery Market Include:

March 2019 – The FDA approved Bidose Inhalation drug delivery device manufactured by Aptar Pharma. This device is meant for treating depression, as was approved as a breakthrough therapy by the US Food and Drug Administration.

August 2019 – Insights Product Development and Nemera entered into a strategic collaboration for providing drug delivery services to patients in North America. This strategy will help strengthen the product portfolio of both the entry-level companies and collectively earn significant revenues from the market.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
9th Floor, Icon Tower, Baner-Mahalunge Road,
Baner, Pune-411045, Maharashtra, India.

Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: [email protected]

Fortune Business Insights™

Linkedin | Twitter | Blogs

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]